The Angels’ Mike Trout, who has been sidelined for the last week due to a neuroma in his right foot, will undergo surgery later this week, the Angels announced. The procedure will remove the neuroma and prematurely end his MVP-caliber season.
Trout, who hasn’t played since September 7, planned to return to the lineup today as a DH, but experienced pain while testing the foot on the field. While Trout and the Angels hoped that he would be able to play out the remainder of the season—if only as a designated hitter—the team has already been eliminated from playoff contention and, with surgery recommended, there’s no reason to push it.
With Trout now on the shelf for the rest of the season, the Angels’ laundry list of injuries only grows: he’ll join Justin Upton and Shohei Ohtani to form a trio of offensive cornerstones that won’t return this year, to say nothing of Andrelton Simmons, who has likewise missed considerable time this year. Those injuries have derailed the Halos’ postseason chances after entering the year as a popular choice to sneak into the playoffs for the first time since 2014.
Trout finishes his superb season with 134 games played, notching yet another season of otherworldly numbers, including a career-best 45 home runs. His .291/.438/.645 slash line gives him a 184 OPS+, the third-best mark of his Hall-of-Fame career.
With the Angels’ season effectively over, one of the few remaining questions was whether Trout would capture his third AL MVP Award. He’s already built a sturdy case, leading the AL in WAR, OBP, SLG, and OPS. He’s not likely to be caught on those fronts, though his closest competition, Alex Bregman, will surely benefit from the additional volume. The Yankees’ D.J. LeMahieu has gotten some buzz, while analytics-driven voters could show some love to Matt Chapman or Marcus Semien, though only Bregman figures to have a real shot at taking votes from the injured Trout.